The prostate cancer crisis defined by the ACS 2023 Cancer Statistics Report is not a surprise for those of us that have been on the forefront of the prostate cancer early detection screening debate during the past decade. We predicted this crisis...Read More
PHEN stood alongside ACS as it announced its commitment to reduce death rates from prostate cancer in all demographics and disparities for Black men by 2035.
Read More
PHEN hosted its 18th Annual Prostate Cancer Disparity Summit, as a virtual event throughout September 2022, which was also Prostate Cancer Awareness month.
Read More
The successful Prostate Cancer Disparity Rally (PCDR) is being expanded to additional cities and states using the same approaches that proved highly effective in 2021 and 2022.
Read More
Most cancer patients have a "depressed" immune system because the disease "weakens" their immune system. To address this problem, scientists have developed immune boosting therapies called cancer immunotherapies.
Read More
Connects Patients With Clinical Trials